What is a stock summary page? Click here for an overview.
Business Description
Cardio Diagnostics Holdings Inc
NAICS : 541714
SIC : 8731
ISIN : US14159C1036
Description
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.81 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.56 | |||||
| Beneish M-Score | -2.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -68.4 | |||||
| 3-Year EPS without NRI Growth Rate | -68.3 | |||||
| 3-Year FCF Growth Rate | -40.2 | |||||
| 3-Year Book Growth Rate | 22.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.75 | |||||
| 9-Day RSI | 32.12 | |||||
| 14-Day RSI | 37.46 | |||||
| 3-1 Month Momentum % | -51.43 | |||||
| 6-1 Month Momentum % | 104.97 | |||||
| 12-1 Month Momentum % | -68.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.91 | |||||
| Quick Ratio | 13.91 | |||||
| Cash Ratio | 12.38 | |||||
| Days Sales Outstanding | 131.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -69 | |||||
| Shareholder Yield % | -62.1 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -23236.11 | |||||
| Net Margin % | -23288.89 | |||||
| FCF Margin % | -14991.67 | |||||
| ROE % | -187.87 | |||||
| ROA % | -150.34 | |||||
| ROIC % | -342.1 | |||||
| 3-Year ROIIC % | -421.21 | |||||
| ROC (Joel Greenblatt) % | -461.34 | |||||
| ROCE % | -167.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 379.8 | |||||
| PB Ratio | 1.83 | |||||
| Price-to-Tangible-Book | 2 | |||||
| EV-to-EBIT | -1.51 | |||||
| EV-to-EBITDA | -1.56 | |||||
| EV-to-Revenue | 351.11 | |||||
| EV-to-FCF | -2.34 | |||||
| Price-to-Net-Current-Asset-Value | 2.23 | |||||
| Price-to-Net-Cash | 2.53 | |||||
| Earnings Yield (Greenblatt) % | -66.23 | |||||
| FCF Yield % | -27.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CDIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cardio Diagnostics Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.036 | ||
| EPS (TTM) ($) | -0.33 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 232.6 | ||
| 14-Day RSI | 37.46 | ||
| 14-Day ATR ($) | 0.056137 | ||
| 20-Day SMA ($) | 0.42979 | ||
| 12-1 Month Momentum % | -68.36 | ||
| 52-Week Range ($) | 0.19 - 1.77 | ||
| Shares Outstanding (Mil) | 52.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cardio Diagnostics Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cardio Diagnostics Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cardio Diagnostics Holdings Inc Frequently Asked Questions
What is Cardio Diagnostics Holdings Inc(CDIO)'s stock price today?
The current price of CDIO is $0.38. The 52 week high of CDIO is $1.77 and 52 week low is $0.19.
When is next earnings date of Cardio Diagnostics Holdings Inc(CDIO)?
The next earnings date of Cardio Diagnostics Holdings Inc(CDIO) is 2025-05-15 Est..
Does Cardio Diagnostics Holdings Inc(CDIO) pay dividends? If so, how much?
Cardio Diagnostics Holdings Inc(CDIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers